The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IBC 2024 | Early screening in lymphoma: current perspectives & future outlooks
In this discussion, Jessica Okosun, MA, MB BChir, MRCP, FRCPath, PhD, Barts Cancer Institute, London, UK, and Sandrine Roulland, PharmD, PhD, Centre d’Immunologie Marseille-Luminy (CIML), Marseille, France, share their thoughts on whether there is a role for early detection and screening in patients with lymphoma, and comment on challenges with implementing this in clinical practice. This session was filmed at IBC 2024, held in Lisbon, Portugal.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
